Infectious Diseases and Systemic Inflammatory Response in Pediatrics, Infectious Diseases Unit, Department of Pediatrics, Institut de Recerca Sant Joan de Déu, Barcelona, Spain; Centre for Biomedical Network Research on Epidemiology and Public Health, CIBERESP, Madrid, Spain.
Pharmacy Department, Sant Joan de Déu Hospital, Barcelona, Spain.
Enferm Infecc Microbiol Clin (Engl Ed). 2022 Feb;40(2):78-81. doi: 10.1016/j.eimce.2021.05.013.
We aimed to describe antimicrobial use (AU) and quality of prescriptions (QP) in a 28-bed medical-surgical PICU of a European referral children's hospital during 2019.
AU data were expressed as days-of-therapy (DOT) over 100 days-present (DP) and as length-of-treatment (LOT). QP was based on monthly cross-sectional point-prevalence surveys. Length-of-stay (LOS), readmission rates (RR), and mortality rates (MR) were also collected.
PICU AU accounted for 13.5% of the global hospital AU; the median PICU density of AU was 1.4 (IQR 1.3-1.5) times higher than that of the rest of the hospital areas. Antibacterials represented 88.5% of the overall AU, cefazolin and amoxicillin-clavulanate being the most used drugs. A high QP rate was observed (149/168 optimal, 88.9%), with room for improvement in prophylactic regimens and de-escalation of broad-spectrum regimens. LOT, LOS, RR, and MR remained stable.
PICU AU represented a major portion of the global hospital AU. Despite high QP rates, prophylactic and broad-spectrum antibiotic regimens were optimizable.
我们旨在描述 2019 年期间,一家欧洲转诊儿童医院的 28 张病床的内科-外科 PICU 中的抗菌药物使用(AU)和处方质量(QP)。
AU 数据表示为 100 天内的治疗日(DOT)与 100 天内的现患率(DP)之比,以及治疗持续时间(LOT)。QP 基于每月的横断面点患病率调查。还收集了住院时间(LOS)、再入院率(RR)和死亡率(MR)。
PICU 的 AU 占医院总 AU 的 13.5%;PICU 的 AU 密度中位数比医院其他区域高 1.4(IQR 1.3-1.5)倍。抗菌药物占总 AU 的 88.5%,头孢唑林和阿莫西林-克拉维酸是最常用的药物。QP 率很高(168 个处方中有 149 个是最佳的,88.9%),预防方案和广谱方案的降级仍有改进的空间。LOT、LOS、RR 和 MR 保持稳定。
PICU 的 AU 占医院总 AU 的很大一部分。尽管 QP 率较高,但预防性和广谱抗生素方案仍可优化。